Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRMD
#2456
CorMedix Inc.
7.130
0
-1.79%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
-1.79%
Mudança mensal
-8.24%
Mudança em 6 meses
-36.90%
Mudança anual
-36.90%
Fechamento anterior
7.260
0
Open
7.130
0
Bid
Ask
Low
7.130
0
High
7.130
0
Volume
99
Mercados
Ações
Cuidados de saúde
CRMD
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
38.02 M
38.73 M
44.5 M
54.98 M
65.18 M
—
Valuation ratios
Enterprise value
240.61 M
122.9 M
142.86 M
163.64 M
487.32 M
2.47 B
Price to earnings ratio
—
-0.02
-5.65
-4.14
-27
19
Price to sales ratio
—
2.27
2 573.79
—
10.97
26.44
Price to cash flow ratio
—
-0.02
-6.91
-5
-9.42
13.81
Price to book ratio
—
0.01
3.06
2.74
5.63
9.71
Enterprise value to EBITDA ratio
-8.88
-4.18
-4.68
-3.35
-22.1
24.24
Profitability ratios
Return on assets %
-0.45
-0.41
-0.48
0.56
-0.15
0.47
Return on equity %
-0.5
-0.45
-0.54
0.66
-0.21
0.72
Return on invested capital %
-12.93 K
-5 882.72
-4 602.58
-7 277.18
-457.82
812.79
Gross margin %
14.37
22
94.29
—
92.66
376.73
Operating margin %
-11.38 K
-15.42 K
-46.82 K
—
-51.43
191.37
EBITDA margin %
-11.32 K
-15.39 K
-46.69 K
—
-50.71
200.13
Net margin %
-9 207.7
-14.77 K
-45.41 K
—
-41.24
249.97
Liquidity ratios
Quick ratio
11.54
12.43
9.44
6.78
3.16
16.4
Current ratio
11.58
12.44
9.44
6.97
3.39
17.36
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0.43
1.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-222.02
-0.6
-0.75
-0.86
0.97
EBIT per share
—
-308.94
-0.76
-0.96
-0.38
1.42
EBITDA per share
—
-308.29
-0.76
-0.96
-0.37
1.47
Total debt per share
—
—
—
—
—
—
Cash per share
—
687.05
1.46
1.49
0.88
5.3
Net current asset value per share
—
697.57
1.48
1.56
1.95
10.51
Tangible book value per share
—
659.05
1.37
1.38
1.41
5.7
Working capital per share
—
641.48
1.32
1.34
1.37
7.44
Book value per share
—
659.05
1.37
1.38
1.44
10.51
Notícias
Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Bet?
Should Investors Buy, Sell or Hold CRMD Stock Ahead of Q4 Earnings?
CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock?
CorMedix Inc. (CRMD) Analyst/Investor Day Transcript
CorMedix Inc. (CRMD) Analyst/Investor Day - Slideshow (NASDAQ:CRMD) 2026-02-11
Citizens reitera classificação de Market Outperform para ações da CorMedix
CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside
Ações da CorMedix sobem após anúncio de plano de recompra de US$ 75 milhões
CorMedix stock rises after announcing $75 million share buyback plan
CorMedix anuncia programa de recompra de ações de US$ 75 milhões
CorMedix announces $75 million share repurchase program